Rakuten Medical

Contact Us

PRNewswire

Home > PRNewswire

Rakuten Aspyrian Announces Name Change to Rakuten Medical

SAN MATEO, February 28, 2019 /PRNewswire/

Rakuten Aspyrian, a biotechnology company developing precision-targeted cancer therapies based on its proprietary Photoimmunotherapy platform, today announced that it has changed its name to Rakuten Medical, Inc. This name more closely reflects the company’s…

Rakuten Medical Logo

Rakuten Medical is a privately funded clinical stage biotechnology company developing tumor-targeted precision therapies. "We are for the cancer patients, to offer them the possibility to battle cancer, to cure the disease, with precision-targeted medicines"

CONQUERING Cancer. For LIFE.

Press Releases

San Mateo, April 8, 2019 - Based on its exclusive license related to photoimmunotherapy, Rakuten … Read More

Rakuten Aspyrian, a biotechnology company developing precision-targeted cancer therapies based on … Read More

Contact Us

Rakuten Medical
11080 Roselle Street
San Diego, CA 92121 USA

info@rakutenaspyrian.com
Tel. 858-925-5619

 

Follow Us

People
×
Innovation
×
Action
×
A Note from Our Chairman

In 2012, my father was diagnosed with pancreatic cancer. I was ready to do anything for him to be cured. With that sole purpose, I read many scientific papers from all over the world, and I met and talked with numerous experts in the field. How could I cure my father’s cancer? I searched every single possibility available.

That is when I found out about photoimmunotherapy that was only at an early stage of research. Although I had many doubts about this completely new approach, desperate for a miracle, I immediately went to meet the researcher.

Everyone was still doubtful at that stage. But the more I heard about this research, the more it made sense. 

I instinctively thought, “This is it.” It was the same feeling I got as when I grasped that the internet would change the world forever. Somehow, wishing to save my father, I immediately made up my mind to support the research personally to speed it up.

Unfortunately, we didn’t make it in time to save my father. But I decided to continue my support. My father who was as an economist always said, “One important mission of corporations is to contribute to humanity.”

Left behind, I resolved to provide this latest treatment to as many people as possible. It will surely be a path fraught with difficulties. But right at this moment there are many who are suffering from cancer, many who wish to save the lives of their loved ones, and I know exactly how they feel.

To provide this treatment as soon as possible, to bring this treatment to as many people as possible, I will not fail to support this research from now on.

Chairman, Rakuten Medical, Inc.

Hiroshi Mikitani

×